380 related articles for article (PubMed ID: 26340951)
21. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
22. The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity.
Knight MJ; Floret L; Patel N; O'Hara J; Rodriguez E
MAbs; 2022; 14(1):2127172. PubMed ID: 36198003
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
Sahin E; Grillo AO; Perkins MD; Roberts CJ
J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
[TBL] [Abstract][Full Text] [Related]
24. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
[TBL] [Abstract][Full Text] [Related]
25. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin dynamics, conformational fluctuations, and nonlinear elasticity and their effects on stability.
Kamerzell TJ; Ramsey JD; Middaugh CR
J Phys Chem B; 2008 Mar; 112(10):3240-50. PubMed ID: 18284232
[TBL] [Abstract][Full Text] [Related]
27. Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol.
Mohamed HE; Mohamed AA; Al-Ghobashy MA; Fathalla FA; Abbas SS
J Pharm Biomed Anal; 2018 Feb; 150():268-277. PubMed ID: 29258046
[TBL] [Abstract][Full Text] [Related]
28. Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold.
Mazzer AR; Perraud X; Halley J; O'Hara J; Bracewell DG
J Chromatogr A; 2015 Oct; 1415():83-90. PubMed ID: 26346187
[TBL] [Abstract][Full Text] [Related]
29. Effects of arginine on photostability and thermal stability of IgG1 monoclonal antibodies.
Maity H; O'Dell C; Srivastava A; Goldstein J
Curr Pharm Biotechnol; 2009 Dec; 10(8):761-6. PubMed ID: 19939215
[TBL] [Abstract][Full Text] [Related]
30. Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody.
Menzen T; Friess W
J Pharm Sci; 2014 Feb; 103(2):445-55. PubMed ID: 24382634
[TBL] [Abstract][Full Text] [Related]
31. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions.
Nicoud L; Jagielski J; Pfister D; Lazzari S; Massant J; Lattuada M; Morbidelli M
J Phys Chem B; 2016 Apr; 120(13):3267-80. PubMed ID: 27007829
[TBL] [Abstract][Full Text] [Related]
33. Buffer-dependent fragmentation of a humanized full-length monoclonal antibody.
Salinas BA; Sathish HA; Shah AU; Carpenter JF; Randolph TW
J Pharm Sci; 2010 Jul; 99(7):2962-74. PubMed ID: 20091831
[TBL] [Abstract][Full Text] [Related]
34. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
[TBL] [Abstract][Full Text] [Related]
35. Effect of pH and light on aggregation and conformation of an IgG1 mAb.
Mason BD; Schöneich C; Kerwin BA
Mol Pharm; 2012 Apr; 9(4):774-90. PubMed ID: 22300012
[TBL] [Abstract][Full Text] [Related]
36. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
[TBL] [Abstract][Full Text] [Related]
37. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
[TBL] [Abstract][Full Text] [Related]
38. Characterization of monoclonal antibody size variants containing extra light chains.
Lu C; Liu D; Liu H; Motchnik P
MAbs; 2013; 5(1):102-13. PubMed ID: 23255003
[TBL] [Abstract][Full Text] [Related]
39. Effects of temperature and osmolytes on competing degradation routes for an IgG1 antibody.
Roberts CJ; Nesta DP; Kim N
J Pharm Sci; 2013 Oct; 102(10):3556-66. PubMed ID: 23873602
[TBL] [Abstract][Full Text] [Related]
40. Circular dichroism spectroscopy as a tool for monitoring aggregation in monoclonal antibody therapeutics.
Joshi V; Shivach T; Yadav N; Rathore AS
Anal Chem; 2014 Dec; 86(23):11606-13. PubMed ID: 25350583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
